Your browser doesn't support javascript.
loading
Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-κB/NLRP3 pathways in inflammatory endothelial cells.
Tang, Juan; Li, Tao; Xiong, Xiaojing; Yang, Qiaoyun; Su, Zedazhong; Zheng, Minming; Chen, Qingwei.
Afiliación
  • Tang J; Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
  • Li T; Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
  • Xiong X; Department of Endocrinology, The First People's Hospital of Ziyang, Sichuan, 641300, China.
  • Yang Q; Department of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
  • Su Z; Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
  • Zheng M; Department of Ophthalmology, The First People's Hospital of Ziyang, Sichuan, 641300, China.
  • Chen Q; Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
J Nanobiotechnology ; 21(1): 460, 2023 Nov 30.
Article en En | MEDLINE | ID: mdl-38037046

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Nanopartículas / Placa Aterosclerótica Límite: Animals Idioma: En Revista: J Nanobiotechnology Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Nanopartículas / Placa Aterosclerótica Límite: Animals Idioma: En Revista: J Nanobiotechnology Año: 2023 Tipo del documento: Article País de afiliación: China